MetaADEDB 2.0 @ LMMD
BMS201038
(MBBCVAKAJPKAKM-UHFFFAOYSA-N)
Structure
SMILES
O=C(c1ccccc1c1ccc(cc1)C(F)(F)F)NC1CCN(CC1)CCCCC1(C(=O)NCC(F)(F)F)c2ccccc2c2c1cccc2
Type(s)
Approved; Investigational
ATC code(s)
C10AX12
Molecular Formula:
C39H37F6N3O2
Molecular Weight:
693.720
Log P:
9.1018
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
2
TPSA:
61.44
CAS Number(s):
182431-12-5
Synonym(s)
1.
BMS201038
2.
AEGR 733
3.
AEGR-733
4.
AEGR733
5.
BMS 201038
6.
BMS-201038
7.
Juxtapid
8.
lomitapide
External Link(s)
MeSHC473731
PubChem Compound9853053
BindingDB50098320
ChEBI72297
CHEMBLCHEMBL354541
DrugBankDB08827
DrugCentral4721
IUPHAR/BPS Guide to PHARMACOLOGY7439
KEGGdr:D09637
Therapeutic Target DatabaseD0H8VY
ZINC27990463
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Weight decreasedFAERS: 355
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
2Therapy cessationFAERS: 242
Canada Vigilance: 9
Canada Vigilance
US FAERS
3NauseaFAERS: 144
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
4Product used for unknown indicationFAERS: 97
Canada Vigilance: 2
Canada Vigilance
US FAERS
5Drug dose omissionFAERS: 93US FAERS
6FlatulenceFAERS: 67
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
7Abdominal discomfortFAERS: 59SIDER
US FAERS
8VomitingFAERS: 52
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
9Inappropriate schedule of drug administrationFAERS: 47US FAERS
10FatigueFAERS: 46
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
11Low density lipoprotein increasedFAERS: 46US FAERS
12MalaiseFAERS: 46
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
13Blood cholesterol increasedFAERS: 40
Canada Vigilance: 1
Canada Vigilance
US FAERS
14HeadacheFAERS: 37SIDER
US FAERS
15Abdominal PainFAERS: 35SIDER
US FAERS
16ConstipationFAERS: 33SIDER
US FAERS
17DizzinessFAERS: 33
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
18PainFAERS: 27
Canada Vigilance: 1
Canada Vigilance
US FAERS
19NasopharyngitisFAERS: 26SIDER
US FAERS
20AstheniaFAERS: 24
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
21Back PainFAERS: 24SIDER
US FAERS
22Chest PainFAERS: 23
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
23InfluenzaFAERS: 23SIDER
US FAERS
24Alanine Aminotransferase IncreasedFAERS: 20
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
25DyspepsiaFAERS: 19SIDER
US FAERS
26ArthralgiaFAERS: 17
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
27Drug administered to patient of inappropriate ageFAERS: 15US FAERS
28Drug ineffectiveFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
29Gastrointestinal sounds abnormalFAERS: 15US FAERS
30SinusitisFAERS: 15SIDER
US FAERS
31MyalgiaFAERS: 13SIDER
US FAERS
32Aspartate Aminotransferase IncreasedFAERS: 12SIDER
US FAERS
33Myocardial InfarctionFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
34Urinary tract infectionFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
35PalpitationsFAERS: 10
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
36Blood glucose increasedFAERS: 9US FAERS
37BronchitisFAERS: 8US FAERS
38PneumoniaFAERS: 8US FAERS
39DehydrationFAERS: 7SIDER
US FAERS
40VertigoFAERS: 7SIDER
US FAERS
41ArthritisFAERS: 6US FAERS
42Atrial FibrillationFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
43Blood triglycerides increasedFAERS: 6US FAERS
44ChillsFAERS: 6SIDER
US FAERS
45HypersensitivityFAERS: 6US FAERS
46Musculoskeletal PainFAERS: 6US FAERS
47PruritusFAERS: 6US FAERS
48SomnolenceFAERS: 6SIDER
US FAERS
49AlopeciaFAERS: 5US FAERS
50Cerebrovascular accidentFAERS: 5US FAERS
51Depressed moodFAERS: 5US FAERS
52Dry skinFAERS: 5SIDER
US FAERS
53DysgeusiaFAERS: 5US FAERS
54EructationFAERS: 5SIDER
US FAERS
55Feeling abnormalFAERS: 5SIDER
US FAERS
56Middle insomniaFAERS: 5US FAERS
57NocturiaFAERS: 5US FAERS
58ArthropathyFAERS: 4US FAERS
59Blood creatine phosphokinase increasedFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
60Blood glucose decreasedFAERS: 4US FAERS
61Burning sensationFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
62CellulitisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
63ChromaturiaFAERS: 4US FAERS
64ErythemaFAERS: 4US FAERS
65Gastrointestinal PainFAERS: 4
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
66GoutFAERS: 4US FAERS
67Incorrect dose administeredFAERS: 4US FAERS
68Joint injuryFAERS: 4US FAERS
69Musculoskeletal discomfortFAERS: 4SIDER
US FAERS
70Neck PainFAERS: 4US FAERS
71PancreatitisFAERS: 4US FAERS
72Therapeutic response unexpectedFAERS: 4US FAERS
73ToothacheFAERS: 4US FAERS
74Angina PectorisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
75AnxietyFAERS: 3US FAERS
76Back disorderFAERS: 3US FAERS
77Bone painFAERS: 3US FAERS
78Cardiac ArrestFAERS: 3US FAERS
79CataractFAERS: 3US FAERS
80Chest discomfortFAERS: 3US FAERS
81Drug administration errorFAERS: 3US FAERS
82Food PoisoningFAERS: 3US FAERS
83HerniaFAERS: 3US FAERS
84HungerFAERS: 3US FAERS
85HypersomniaFAERS: 3US FAERS
86HypophagiaFAERS: 3US FAERS
87HypotensionFAERS: 3US FAERS
88Incision site painFAERS: 3US FAERS
89Intentional product misuseFAERS: 3US FAERS
90Joint swellingFAERS: 3SIDER
US FAERS
91Limb injuryFAERS: 3US FAERS
92Lower respiratory tract infectionFAERS: 3US FAERS
93Musculoskeletal chest painFAERS: 3US FAERS
94Neurostimulator implantationFAERS: 3US FAERS
95No adverse eventFAERS: 3US FAERS
96Peripheral swellingFAERS: 3US FAERS
97StressFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
98Throat irritationFAERS: 3US FAERS
99Trigeminal NeuralgiaFAERS: 3US FAERS
100UrticariaFAERS: 3US FAERS
101Blood creatinine increasedFAERS: 2US FAERS
102Blood potassium increasedFAERS: 2US FAERS
103Bowel movement irregularityFAERS: 2US FAERS
104Carotid artery occlusionFAERS: 2US FAERS
105CholelithiasisFAERS: 2US FAERS
106Drug effect incompleteFAERS: 2US FAERS
107EpistaxisFAERS: 2US FAERS
108Exposure via fatherFAERS: 2US FAERS
109Eye InfectionFAERS: 2US FAERS
110Eye painFAERS: 2US FAERS
111Feeling ColdFAERS: 2US FAERS
112Flank PainFAERS: 2US FAERS
113Head discomfortFAERS: 2US FAERS
114High density lipoprotein increasedFAERS: 2US FAERS
115Hormone level abnormalFAERS: 2US FAERS
116HypothyroidismFAERS: 2US FAERS
117InfectionFAERS: 2SIDER
US FAERS
118InflammationFAERS: 2US FAERS
119Initial insomniaFAERS: 2US FAERS
120Intervertebral disc compressionFAERS: 2US FAERS
121Joint stiffnessFAERS: 2US FAERS
122LabyrinthitisFAERS: 2US FAERS
123LethargyFAERS: 2US FAERS
124Ligament ruptureFAERS: 2US FAERS
125Lipids abnormalFAERS: 2US FAERS
126Low density lipoprotein abnormalFAERS: 2US FAERS
127Muscle tightnessFAERS: 2US FAERS
128Oropharyngeal painFAERS: 2US FAERS
129Poor quality sleepFAERS: 2US FAERS
130PresyncopeFAERS: 2US FAERS
131Product use issueFAERS: 2US FAERS
132Rotator cuff syndromeFAERS: 2US FAERS
133Sinus headacheFAERS: 2US FAERS
134SwellingFAERS: 2US FAERS
135SyncopeFAERS: 2US FAERS
136Tension HeadacheFAERS: 2US FAERS
137TinnitusFAERS: 2US FAERS
138XanthomaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
139AbasiaFAERS: 1US FAERS
140Abdominal tendernessFAERS: 1SIDER
US FAERS
141Acute Coronary SyndromeFAERS: 1US FAERS
142Adverse eventFAERS: 1US FAERS
143AgitationFAERS: 1US FAERS
144Amaurosis FugaxFAERS: 1US FAERS
145AmnesiaFAERS: 1US FAERS
146AneurysmFAERS: 1US FAERS
147Anorectal discomfortFAERS: 1SIDER
US FAERS
148Aortic AneurysmFAERS: 1US FAERS
149Aortic occlusionFAERS: 1US FAERS
150AphoniaFAERS: 1US FAERS
151ArteriosclerosisFAERS: 1US FAERS
152Atrial FlutterFAERS: 1US FAERS
153Atypical pneumoniaFAERS: 1US FAERS
154Bile output increasedFAERS: 1US FAERS
155Bladder discomfortFAERS: 1US FAERS
156BlindnessFAERS: 1US FAERS
157Blood chloride abnormalFAERS: 1US FAERS
158Blood creatine phosphokinase MB increasedFAERS: 1US FAERS
159Blood creatinine abnormalFAERS: 1US FAERS
160Blood iron decreasedFAERS: 1US FAERS
161Blood potassium decreasedFAERS: 1SIDER
US FAERS
162Blood sodium abnormalFAERS: 1US FAERS
163Blood urea abnormalFAERS: 1US FAERS
164Blood urine presentFAERS: 1US FAERS
165BronchopneumoniaFAERS: 1US FAERS
166BrucellosisFAERS: 1US FAERS
167CalcinosisFAERS: 1US FAERS
168Cardiac ablationFAERS: 1US FAERS
169Clostridium difficile infectionFAERS: 1US FAERS
170Coagulation time abnormalFAERS: 1US FAERS
171ColitisFAERS: 1US FAERS
172Coronary Artery DiseaseFAERS: 1US FAERS
173CystitisFAERS: 1US FAERS
174Deep Vein ThrombosisFAERS: 1US FAERS
175Depressed Level of ConsciousnessFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
176Device occlusionFAERS: 1US FAERS
177Diabetes MellitusFAERS: 1US FAERS
178Diabetic KetoacidosisFAERS: 1US FAERS
179DiplopiaFAERS: 1US FAERS
180DiscomfortFAERS: 1SIDER
US FAERS
181DiverticulitisFAERS: 1US FAERS
182DysarthriaFAERS: 1US FAERS
183DysuriaFAERS: 1US FAERS
184Escherichia urinary tract infectionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
185Exposure to toxic agentFAERS: 1US FAERS
186Feeling jitteryFAERS: 1US FAERS
187FibromyalgiaFAERS: 1US FAERS
188Food AllergyFAERS: 1US FAERS
189Gastric BypassFAERS: 1US FAERS
190Gastric pH decreasedFAERS: 1US FAERS
191Gastric ulcerFAERS: 1US FAERS
192GastritisFAERS: 1SIDER
US FAERS
193GastroenteritisFAERS: 1SIDER
US FAERS
194Gastrointestinal disorder postoperativeFAERS: 1US FAERS
195Gastrointestinal motility disorderFAERS: 1US FAERS
196Gastrointestinal ulcerFAERS: 1US FAERS
197Gastrointestinal viral infectionFAERS: 1US FAERS
198General symptomFAERS: 1US FAERS
199Gluten sensitivityFAERS: 1US FAERS
200Granuloma AnnulareFAERS: 1US FAERS
201Grief reactionFAERS: 1US FAERS
202Hepatic cancer stage IVFAERS: 1US FAERS
203HostilityFAERS: 1US FAERS
204IleusFAERS: 1US FAERS
205Impaired driving abilityFAERS: 1US FAERS
206Infrequent bowel movementsFAERS: 1US FAERS
207Intercepted drug dispensing errorFAERS: 1US FAERS
208Irritable Bowel SyndromeFAERS: 1US FAERS
209LacerationFAERS: 1US FAERS
210Lactose IntoleranceFAERS: 1US FAERS
211Large intestine perforationFAERS: 1US FAERS
212Limb discomfortFAERS: 1US FAERS
213Lip swellingFAERS: 1US FAERS
214Loss of personal independence in daily activitiesFAERS: 1US FAERS
215Maternal exposure during pregnancyFAERS: 1US FAERS
216Medication monitoring errorFAERS: 1US FAERS
217Memory impairmentFAERS: 1US FAERS
218Mesenteric arterial occlusionFAERS: 1US FAERS
219Metabolic function test abnormalFAERS: 1US FAERS
220Muscle strainFAERS: 1US FAERS
221NephrolithiasisFAERS: 1US FAERS
222NervousnessFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
223NeuralgiaFAERS: 1US FAERS
224Night sweatsFAERS: 1US FAERS
225ObesityFAERS: 1US FAERS
226Ocular icterusFAERS: 1US FAERS
227OnychoclasisFAERS: 1US FAERS
228Ophthalmoplegic MigraineFAERS: 1US FAERS
229Oral infectionFAERS: 1US FAERS
230OsteomyelitisFAERS: 1US FAERS
231OsteoporosisFAERS: 1US FAERS
232Paranasal sinus discomfortFAERS: 1US FAERS
233Paratyphoid FeverFAERS: 1US FAERS
234Poor peripheral circulationFAERS: 1US FAERS
235Post procedural complicationFAERS: 1US FAERS
236Post-tussive vomitingFAERS: 1US FAERS
237Pre-existing condition improvedFAERS: 1US FAERS
238Product selection errorFAERS: 1US FAERS
239Pulmonary congestionFAERS: 1US FAERS
240Renal cystFAERS: 1US FAERS
241Renal painFAERS: 1US FAERS
242Respiratory distressFAERS: 1US FAERS
243Retinal Vein OcclusionFAERS: 1US FAERS
244Rheumatoid ArthritisFAERS: 1US FAERS
245Skin lesionFAERS: 1US FAERS
246StomatitisFAERS: 1US FAERS
247TachycardiaFAERS: 1US FAERS
248Terminal stateFAERS: 1US FAERS
249Therapeutic response changedFAERS: 1US FAERS
250ThrombosisFAERS: 1US FAERS
251Transaminases increasedFAERS: 1SIDER
US FAERS
252TremorFAERS: 1US FAERS
253Typhoid FeverFAERS: 1US FAERS
254Unevaluable eventFAERS: 1US FAERS
255Urethral StenosisFAERS: 1US FAERS
256Vascular occlusionFAERS: 1US FAERS
257Vascular procedure complicationFAERS: 1US FAERS
258Vascular stenosisFAERS: 1US FAERS
259Visual ImpairmentFAERS: 1US FAERS
260Vitreous floatersFAERS: 1US FAERS
261furuncleFAERS: 1US FAERS
262Blood alkaline phosphatase increasedSIDER
263Blood and lymphatic system disordersSIDER
264Ear and labyrinth disordersSIDER
265Early satietySIDER
266EcchymosisSIDER
267Epigastric discomfortSIDER
268Gamma-Glutamyltransferase IncreasedSIDER
269Gastric DilatationSIDER
270Gastrointestinal infectionSIDER
271HepatomegalySIDER
272HepatotoxicitySIDER
273InfestationSIDER
274MalnutritionSIDER
275Neutrophil count decreasedSIDER
276Neutrophil percentage increasedSIDER
277PapuleSIDER
278Pharyngeal lesionSIDER
279Pharyngolaryngeal PainSIDER
280Product dose omissionCanada Vigilance: 4Canada Vigilance
281Rash erythematousSIDER
282Reaction gastrointestinalSIDER
283Rectal tenesmusSIDER
284RegurgitationSIDER
285Stomach dilation procedureSIDER
286Upper-airway cough syndromeSIDER
287Vascular stent occlusionCanada Vigilance: 1Canada Vigilance
288White blood cell count decreasedSIDER
289nervous system disorderSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120236

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.